The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic
Open Access
- 7 December 2022
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (2) , 1809-1816
Abstract
The renin-angiotensin system is known to maintain blood pressure and body fluids. However, it has been found to consist of at least two major constituents,Keywords
This publication has 59 references indexed in Scilit:
- MRGD, a MAS-related G-protein Coupled Receptor, Promotes Tumorigenisis and Is Highly Expressed in Lung CancerPLOS ONE, 2012
- Angiotensin‐(1‐7) attenuates metastatic prostate cancer and reduces osteoclastogenesisThe Prostate, 2012
- Angiotensin‐(1‐7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt‐1The Prostate, 2012
- Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapyCancer Letters, 2011
- The renin–angiotensin system and cancer: old dog, new tricksNature Reviews Cancer, 2010
- Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1–7/MAS-1-dependent pathwaysAmerican Journal of Physiology-Renal Physiology, 2010
- Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF‐7 breast cancer cells survival via PI3‐kinase/Akt pathwayJournal of Cellular Physiology, 2010
- The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancerOncology Reports, 2010
- Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factorMolecular Cancer Therapeutics, 2009
- Emerging Evidence for a Functional Angiotensin-Converting Enzyme 2-Angiotensin-(1-7)-Mas Receptor AxisHypertension, 2007